Oramed Pharmaceuticals is on the Cruelty Free Investing animal use list as the company performs animal testing in the research and development of some of their pharmaceutical solutions.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“Data and other results demonstrating the applicability of this platform toward delivery of insulin and GLP-1 to manage diabetes, as assessed in animal models, healthy volunteers and in both type 1 and type 2 diabetes patients, will be presented.” Read the following article
Oramed Pharmaceuticals, Inc. engages in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides.
Company Website: http://www.oramed.com